ACAD

ACADIA Pharmaceuticals (ACAD)

About ACADIA Pharmaceuticals (ACAD)

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Details

Daily high

$17.21

Daily low

$16.49

Price at open

$16.51

52 Week High

$31.93

52 Week Low

$14.15

Market cap

2.8B

Dividend yield

0.00%

Volume

4.9M

Avg. volume

1.8M

P/E ratio

21.84

ACADIA Pharmaceuticals News